eMedicine Specialties > Pediatrics: General Medicine > Hematology

Anemia, Acute: Differential Diagnoses & Workup

Author: Margaret T Lee, MD,, Associate Professor, Department of Pediatrics, Division of Pediatric Hematology, Children's Hospital of New York, Columbia University
Contributor Information and Disclosures

Updated: Apr 17, 2009

Differential Diagnoses

Anemia of Prematurity
Paroxysmal Cold Hemoglobinuria
Anemia, Chronic
Parvovirus B19 Infection
Anemia, Megaloblastic
Porphyria, Acute
Evans Syndrome
Pyruvate Kinase Deficiency
Hemoglobin H Disease
Sickle Cell Anemia
Hemolytic Disease of Newborn
Systemic Lupus Erythematosus
Hemolytic-Uremic Syndrome
Thalassemia
Hereditary Elliptocytosis and Related Disorders
Thalassemia Intermedia
Hypothyroidism
Thymoma
Myelofibrosis
Transient Erythroblastopenia of Childhood

Other Problems to Be Considered

Acute blood loss
Anemia of inflammation/infection
Aplastic anemia
Autoimmune hemolytic anemia
Chronic renal failure
Congenital dyserythropoietic anemia
Diamond-Blackfan anemia
Erythrophagocytosis
Fanconi anemia
G-6-PD deficiency
Hereditary spherocytosis
Iron deficiency anemia
Microangiopathic hemolytic anemia
Osteopetrosis
Paroxysmal nocturnal hemoglobinuria
Pure red cell aplasia
Sideroblastic anemia
Unstable hemoglobinopathy

Workup

Laboratory Studies

  • To evaluate anemia, obtain initial laboratory tests, including CBC count, reticulocyte count, and review of the peripheral smear (see Media file 1).

    Algorithm for diagnostic approach and workup of a...

    Algorithm for diagnostic approach and workup of anemia in children. Hb=hemoglobin; Hct=hematocrit; HS=hereditary spherocytosis; HE=hereditary elliptocytosis; G-6-PD=glucose-6-phosphate dehydrogenase; PK=pyruvate kinase; HUS=hemolytic uremic syndrome; TTP=thrombotic thrombocytopenic purpura; DIC=disseminated intravascular coagulation; DBA=Diamond-Blackfan anemia.

    Algorithm for diagnostic approach and workup of a...

    Algorithm for diagnostic approach and workup of anemia in children. Hb=hemoglobin; Hct=hematocrit; HS=hereditary spherocytosis; HE=hereditary elliptocytosis; G-6-PD=glucose-6-phosphate dehydrogenase; PK=pyruvate kinase; HUS=hemolytic uremic syndrome; TTP=thrombotic thrombocytopenic purpura; DIC=disseminated intravascular coagulation; DBA=Diamond-Blackfan anemia.


    • Base interpretation of the hemoglobin and hematocrit levels on the reference range for the specific age group. Some laboratories provide only a uniform reference range for the entire pediatric age group and not for specific age groups. Hemoglobin and hematocrit levels can be used interchangeably, depending on professional preference and familiarity. Essentially, the hematocrit level is 3 times the hemoglobin value.
    • If the patient is anemic, look at the red cell indices (mean corpuscular volume [MCV], mean corpuscular hemoglobin [MCH], mean corpuscular hemoglobin concentration [MCHC]). Note that reference ranges for these parameters also vary with age. Of these, the MCV is particularly helpful in classifying anemia. Microcytic anemia suggests iron deficiency, lead poisoning, or thalassemia; macrocytosis suggests folate/B-12 deficiency or reactive reticulocytosis.
    • Another valuable parameter in classifying anemia is the RBC distribution width (RDW). This is the statistical description of the heterogeneity of RBC sizes. It is increased in anisocytosis (variable sizes of red cells), such as when increased reticulocytes are present.
    • Reticulocytes are immature nonnucleated RBCs that indicate active erythropoiesis.
      • The relative reticulocyte count is useful in differentiating whether the anemia is caused by decreased production, increased destruction, or loss of RBCs. An elevated number of reticulocytes (eventually) is observed in individuals with anemia caused by hemolysis or blood loss; note that the absence of reticulocytosis may simply reflect a "lag" in the response to the acute onset of anemia.
      • The term reticulocyte count is often used inaccurately to refer to the percentage of reticulocytes, a value that must be interpreted in light of the degree of anemia. Thus, a finding of 2-3% reticulocytes (vs the normal value of approximately 1%) in a patient whose hemoglobin is only one third to one half of normal does not indicate a reticulocyte "response." Some clinicians prefer to use either the absolute number of reticulocytes per mcl of blood or a reticulocyte percentage "corrected" for the degree of anemia. (Corrected reticulocyte count = patient hematocrit/normal hematocrit X %reticulocyte count)
    • Examination of the peripheral smear helps identify the cause of the anemia by recognizing abnormal cell morphology. The following are examples of abnormal cell morphology:
      • Schistocytes or fragmented cells (microangiopathic hemolytic anemia)
      • Spherocytes (hereditary spherocytosis, autoimmune hemolytic anemia)
      • Ghost or bite cells (G-6-PD deficiency)
      • Sickle-shaped cells (sickle cell disease)
      • Target cells (hemoglobin C): These   can be seen nonspecifically in other conditions such as thalassemia and other hemoglobinopathies; however, hemoglobin C is the classic, most common example.
      • Stippled red blood cells (nonspecific but may suggest lead poisoning)
      • Increased polychromasia (reticulocytosis)
      • Crenated or spiculated cells (liver disease, uremia, abetalipoproteinemia)
    • Recognizing that normal RBC morphology does not rule out hemolysis is important.
  • Additional laboratory tests that may be indicated in the diagnosis and treatment of patients with acute anemia include the following:
    • Bilirubin level, lactate dehydrogenase (hemolytic anemia)
    • Direct antiglobulin or Coombs test (autoimmune hemolytic anemia) 
    • Hemoglobin electrophoresis (hemoglobinopathies)
    • Red cell enzyme studies (eg, G-6-PD, pyruvate kinase)
    • Osmotic fragility (spherocytosis)
    • Iron, total iron-binding capacity (TIBC), ferritin (iron deficiency anemia)
    • Folate, vitamin B-12 (macrocytic/megaloblastic anemia)
    • Blood typing and crossmatching to assess possible isoimmune anemia in a neonate and to prepare for transfusion
    • Bone marrow aspiration and biopsy
    • Viral titers (eg, Epstein-Barr virus, cytomegalovirus)
    • BUN and creatinine levels to assess renal function
    • Thyroxine (T4)/thyroid-stimulating hormone (TSH) to rule out hypothyroidism

Imaging Studies

  • Chest radiography in patients who may have congestive heart failure (CHF) and to rule out mediastinal mass (associated with acute leukemia) or thymoma (associated with paroxysmal nocturnal hemoglobinuria)
  • Abdominal ultrasonography to assess for gallstones or splenomegaly in hemolytic anemia
  • CT scanning to evaluate occult bleeding in blunt trauma or bleeding disorder
  • Radioactively tagged RBC radionuclide scans, occasionally used to localize site of GI bleeding when the source is unclear (a common example in pediatrics is Meckel scan used in the diagnosis of Meckel diverticulum)

Other Tests

  • Family studies such as sending CBC count, smear review, and hemoglobin electrophoresis from parents may be helpful in making a diagnosis of conditions such as hereditary spherocytosis or thalassemia.

Procedures

  • Rarely indicated in isolated acute anemia, bone marrow aspiration and biopsy are indicated in the evaluation of possible bone marrow failure or malignancy. Suppression of the platelet count or WBC (neutrophil) count, in association with anemia, often warrants an examination of the bone marrow.

More on Anemia, Acute

Overview: Anemia, Acute
Differential Diagnoses & Workup: Anemia, Acute
Treatment & Medication: Anemia, Acute
Follow-up: Anemia, Acute
Multimedia: Anemia, Acute
References

References

  1. Sherry B, Mei Z, Yip R. Continuation of the decline in prevalence of anemia in low-income infants and children in five states. Pediatrics. Apr 2001;107(4):677-82. [Medline].

  2. Hare GM, Tsui AK, McLaren AT, Ragoonanan TE, Yu J, Mazer CD. Anemia and cerebral outcomes: many questions, fewer answers. Anesth Analg. Oct 2008;107(4):1356-70. [Medline].

  3. Niemeyer CM, Baumann I. Myelodysplastic syndrome in children and adolescents. Semin Hematol. Jan 2008;45(1):60-70. [Medline].

  4. Transfusion Task Force. Amendments and corrections to the 'Transfusion Guidelines for neonates and older children' (BCSH, 2004a); and to the 'Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatant' (BCSH, 2004b). Br J Haematol. Feb 2007;136(3):514-6. [Medline].

  5. Bateman ST, Lacroix J, Boven K, et al. Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. Am J Respir Crit Care Med. Jul 1 2008;178(1):26-33. [Medline].

  6. Abshire TC. The anemia of inflammation. A common cause of childhood anemia. Pediatr Clin North Am. Jun 1996;43(3):623-37. [Medline].

  7. Armano R, Gauvin F, Ducruet T, Lacroix J. Determinants of red blood cell transfusions in a pediatric critical care unit: a prospective, descriptive epidemiological study. Crit Care Med. Nov 2005;33(11):2637-44. [Medline].

  8. Cusick SE, Mei Z, Cogswell ME. Continuing anemia prevention strategies are needed throughout early childhood in low-income preschool children. J Pediatr. Apr 2007;150(4):422-8, 428.e1-2. [Medline].

  9. Graham EA. The changing face of anemia in infancy. Pediatr Rev. May 1994;15(5):175-83; quiz 184. [Medline].

  10. [Best Evidence] Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. Apr 19 2007;356(16):1609-19. [Medline].

  11. Liet JM, Paranon S, Baraton L, Dejode JM, Roze JC. Is a prophylactic treatment by erythropoietin relevant to reduce red blood cell transfusion in the pediatric intensive care unit?. Pediatr Crit Care Med. Nov 2006;7(6):541-4. [Medline].

  12. Ohls RK. Evaluation and treatment of anemia in the neonate. In: Christensen RD, Fletcher J, eds. Hematologic Problems in the Neonate. WB Saunders Co; 2000:137-69.

  13. [Best Evidence] Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev. Jul 19 2006;3:CD004863. [Medline].

  14. Oski FA, Brugnara C, Nathan DG. A diagnostic approach to the anemic patient. In: Nathan and Oski's Hematology of Infancy and Childhood. 5th ed. Harcourt Health Sciences; 1998:375-84.

  15. Walters MC, Abelson HT. Interpretation of the complete blood count. Pediatr Clin North Am. Jun 1996;43(3):599-622. [Medline].

Further Reading

Keywords

anemia, low hemoglobin, low hematocrit, anemic, reduced red cell mass, diminished oxygen-carrying capacity, hematologic abnormality, decreased or ineffective red cell production, increased red cell destruction, blood loss, acute anemia, congestive heart failure, CHF, hemolysis, hemorrhage, thalassemia, splenectomy, Fanconi anemia, aplastic anemia, treatment, diagnosis, myelofibrosis, leukemia, sickle cell disease, systemic lupus erythematosus, chronic renal failure, iron deficiency anemia, X-linked disorders, tachycardia, gallop rhythm, tachypnea, cardiomegaly, hepatomegaly, Diamond-Blackfan anemia, transient erythroblastopenia of childhood, hypothyroidism, pyruvate kinase deficiency

Contributor Information and Disclosures

Author

Margaret T Lee, MD,, Associate Professor, Department of Pediatrics, Division of Pediatric Hematology, Children's Hospital of New York, Columbia University
Margaret T Lee, MD, is a member of the following medical societies: American Society of Hematology
Disclosure: Nothing to disclose.

Medical Editor

J Martin Johnston, MD, Associate Professor of Pediatrics, Mercer University School of Medicine; Director of Pediatric Hematology/Oncology, Backus Children's Hospital; Consulting Oncologist/Hematologist, St Damien's Pediatric Hospital
J Martin Johnston, MD is a member of the following medical societies: American Society of Pediatric Hematology/Oncology
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Steven K Bergstrom, MD, Assistant to the Chairman, Department of Pediatrics, Division of Hematology-Oncology, Kaiser Permanente Medical Center of Oakland
Steven K Bergstrom, MD is a member of the following medical societies: Alpha Omega Alpha, American Society of Clinical Oncology, American Society of Hematology, American Society of Pediatric Hematology/Oncology, Children's Oncology Group, and International Society for Experimental Hematology
Disclosure: Nothing to disclose.

CME Editor

Samuel Gross, MD, Professor Emeritus, Department of Pediatrics, University of Florida; Clinical Professor, Department of Pediatrics, University of North Carolina; Adjunct Professor, Department of Pediatrics, Duke University
Samuel Gross, MD is a member of the following medical societies: American Association for Cancer Research, American Society for Blood and Marrow Transplantation, American Society of Clinical Oncology, American Society of Hematology, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Chief Editor

Robert J Arceci, MD, PhD, King Fahd Professor of Pediatric Oncology, Professor of Pediatrics, Oncology and the Cellular and Molecular Medicine Graduate Program, Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine
Robert J Arceci, MD, PhD is a member of the following medical societies: American Association for Cancer Research, American Association for the Advancement of Science, American Pediatric Society, American Society of Hematology, and American Society of Pediatric Hematology/Oncology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.